I have hep c genotype 2 but have already gone through the two drug therapy about ten years ago. It was not detectable at first but returned six months later. This new inhibitor will cure me hopefully but I am excluded from the clinical trials because I am not naive. My question is if I am excluded from the trials, will I also be excluded from the drug when it is ok'd by the FDA?